Valuation: Aprogen Biologics Inc.

Market Cap 27B 17.83M 15.6M 14.38M 13.33M 25.3M 1.69B 25.7M 172M 67.04M 835M 66.92M 65.47M 2.89B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 204B 135M 118M 109M 101M 191M 12.79B 194M 1.3B 507M 6.31B 506M 495M 21.82B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
95.86%
Yield 2024 *
-
Yield 2025 -
1 day-1.20%
1 week-3.30%
Current month-0.73%
1 month-23.65%
3 months-46.61%
6 months-74.26%
Current year-73.67%
1 week 1,972
Extreme 1972
2,250
1 month 1,869
Extreme 1869
2,880
Current year 1,869
Extreme 1869
8,490
1 year 1,869
Extreme 1869
10,395
3 years 1,869
Extreme 1869
108,600
5 years 1,869
Extreme 1869
204,750
10 years 1,869
Extreme 1869
1,000,000
Manager TitleAgeSince
Chief Executive Officer 63 13/10/2023
Chief Executive Officer 70 01/04/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 01/04/2012
Director/Board Member 65 23/03/2020
Director/Board Member 63 13/10/2023
Date Insider Type Main position Quantity % Market Cap.
28/06/24Expiration

Chief Executive Officer

21,884 0.0164%
28/06/24Fiscal year 1,180 0.0009%
28/06/24Fiscal year

Executive/Senior Manager

6,183 0.0046%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-3.30%-79.60%-96.30% 17.83M
+2.96%+3.01%+59.87%+173.31% 1,102B
+3.05%+5.23%+72.11%+67.81% 643B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 336B
+1.36%+0.17%+29.90%+49.33% 288B
+1.98%+4.08%-25.78%-39.02% 222B
+0.45%+1.65%+25.65%+68.35% 199B
+5.21%+7.93%+21.99%+83.23% 169B
+1.48%-0.04%-4.64%-32.25% 137B
Average +0.65%+1.63%+16.28%+38.50% 354.51B
Weighted average by Cap. +1.51%+1.86%+41.96%+87.59%

Financials

2024 2025
Net sales 67.38B 44.48M 38.93M 35.87M 33.25M 63.12M 4.22B 64.14M 430M 167M 2.08B 167M 163M 7.2B 73.23B 48.34M 42.3M 38.99M 36.14M 68.6M 4.59B 69.7M 467M 182M 2.26B 181M 178M 7.83B
Net income -105B -69.3M -60.65M -55.89M -51.81M -98.34M -6.58B -99.93M -670M -261M -3.25B -260M -255M -11.22B -170B -112M -98.4M -90.69M -84.06M -160M -10.67B -162M -1.09B -423M -5.27B -422M -413M -18.2B
Net Debt 116B 76.38M 66.84M 61.6M 57.1M 108M 7.25B 110M 739M 287M 3.58B 287M 281M 12.37B 177B 117M 102M 94.33M 87.43M 166M 11.1B 169M 1.13B 440M 5.48B 439M 430M 18.94B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
379
Date Price Change Volume
07/07/26 ₩2,050.00 -1.20% 119,088
06/07/26 ₩2,075.00 -1.43% 41,860
03/07/26 ₩2,105.00 +5.25% 48,634
02/07/26 ₩2,000.00 -4.08% 59,392
01/07/26 ₩2,085.00 +0.97% 87,454
  1. Stock Market
  2. Stocks
  3. A003060 Stock